Top News

Maharashtra’s FDA names Snapdeal Co-Founder & CEO Kunal Bahl, others in FIR

Maharashtra’s
Food and Drugs Administration (FDA) has reportedly ordered the filing of an FIR
against e-commerce firm Snapdeal.com’s Co-Founder & CEO Kunal Bahl and
directors of the company in a case related to alleged online sale of medicines,
including prescription drugs.

Maharashtra’s
Food and Drugs Administration (FDA) has reportedly ordered the filing of an FIR
against e-commerce firm Snapdeal.com’s Co-Founder & CEO Kunal Bahl and
directors of the company in a case related to alleged online sale of medicines,
including prescription drugs.

According to an Indian
Express
reports, FDA Commissioner Harshadeep Kamble said that the filing of an
FIR has been ordered against Bahl as well as directors of Snapdeal. An FIR is
the first step in an investigation. A conviction could mean a jail term of up
to five years and a fine of not less than Rs 1 lakh.

FDA had even
raided the company’s Mumbai premises in this regard last month. At that time,
Snapdeal had said it was delisting the drugs from its portal and was assisting
the regulator in the investigation, reports the Indian Express.

FDA had earlier
issued a notice to the company and it was asked to furnish details of the drugs
offered for sale, distribution and exhibited for sale on its website
Snapdeal.com.

The raid
followed FDA receiving information that various medicines, including
prescription drugs, were being sold online through Snapdeal.com. As per the
law, only a licensed retailer can sell drugs, and that too on the basis of
prescription of a doctor, Kamble said, adding such type of online sale of drugs
is not allowed as self medication can be harmful.

Kamble said in
the report that FDA in Maharashtra is also investigating other online
marketplaces. Kamble said an FDA official placed an order on April 22 for
contraceptive drugs made by two leading pharmaceutical companies. Two days
later, the official received the drugs, following which he said FDA decided to
proceed against Snapdeal.

According
to the report, citing officials, FDA also claimed to have found that Snapdeal
“displayed and offered for sale about 45 drugs with objectionable claims
which contravene the provisions of the Drugs & Magic Remedies Act”. 

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close